EX-99.1
3
s110627_ex99-1.htm
EXHIBIT 99.1
Exhibit 99.1
FRED'S COMPLETES SALE OF SPECIALTY
PHARMACY UNIT
MEMPHIS, Tenn. (June 4, 2018) - Fred's, Inc. (NASDAQ:
FRED) has closed the previously announced sale of certain assets of EntrustRx, its specialty pharmacy unit, to a subsidiary of
CVS Health Corporation. The aggregate consideration paid was $40.0 million, plus an amount equal to the value of inventory of EntrustRx.
Commenting on the sale, Fred's Interim CEO Joe Anto said:
"We are pleased to conclude the sale of EntrustRx, an important step in our plans to monetize non-core assets as part of
our broader turnaround efforts. The cash proceeds will allow us to pay down a significant portion of our debt and also be used
for general corporate purposes".
Fred's was advised on this transaction
by Covington Associates and by Bass Berry & Sims.
About Fred's Inc.
Tracing its history back to an original store in Coldwater,
Mississippi, opened in 1947, today Fred's, Inc. operates approximately 600 general merchandise and pharmacy stores, including
12 franchised locations. With unique store formats and strategies that combine the best elements of a value-focused retailer with
a healthcare-focused drug store, Fred's stores offer frequently purchased items that address the everyday needs of its customers.
This includes nationally recognized brands, proprietary Fred's label products, and a full range of value-priced selections.
For more information about the Company, visit Fred's website at
www.fredsinc.com
.
Forward Looking Statements
Comments in this news release that are not historical facts
are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those
projected in the forward-looking statements. A reader can identify forward-looking statements because they are not limited to historical
facts or they use such words as "outlook", "guidance", "may", "should", "could,"
"believe", "anticipate", "plan", "expect", "estimate", "forecast,"
"goal", "intend", "committed", "continue", or "will likely result"
and similar expressions that concern the Company's strategy, plans, intentions or beliefs about future occurrences or results.
These risks and uncertainties include, but are not limited to (i) the competitive nature of the industries in which we operate;
(ii) the implementation of our strategic plan, and its impact on our sales, costs and operations; (iii) utilizing our existing
and new stores and increasing our pharmacy department presence in new and existing stores; (iv) our reliance on a single supplier
of pharmaceutical products; (v) our pharmaceutical drug pricing; (vi) reimbursement rates and the terms of our agreements with
pharmacy benefit management companies; (vii) our private brands; (viii) the seasonality of our business and the impact of adverse
weather conditions; (ix) operational difficulties; (x) merchandise supply and pricing; (xi) consumer demand and product mix; (xii)
delayed openings and operating new stores and distribution facilities; (xiii) our employees; (xiv) risks relating to payment processing;
(xv) our computer system, and the processes supported by our information technology infrastructure; (xvi) our ability to protect
the personal information of our customers and employees; (xvii) cyber-attacks; (xviii) changes in governmental regulations; (xix)
the outcome of legal proceedings, including claims of product liability; (xx) insurance costs; (xxi) tax assessments and unclaimed
property audits; (xxii) current economic conditions; (xxiii) changes in third-party reimbursements; (xxiv) the terms of our existing
and future indebtedness; (xxv) our acquisitions and the ability to effectively integrate businesses that we acquire; (xxvi) our
ability to pay dividends; and the factors listed under "Risk Factors" in the Company's most recent Annual Report
on Form 10-K and any subsequent quarterly filings on Form 10-Q filed with the Securities and Exchange Commission. Forward-looking
statements speak only as of the date made. The Company undertakes no obligation to release revisions to these forward-looking statements
to reflect events or circumstances after the date hereof or to reflect the occurrence of unforeseen events, except as required
to be reported under the rules and regulations of the Securities and Exchange Commission.
Contacts
Liolios
Sean McGowan or Cody Slach, 949-574-3860
FRED@liolios.com

EX - 99 . 1 3 s110627 _ ex99 - 1 . htm EXHIBIT 99 . 1 Exhibit 99 . 1 FRED 'S COMPLETES SALE OF SPECIALTY PHARMACY UNIT MEMPHIS , Tenn . ( June 4 , 2018 ) - Fred ' s , Inc . ( NASDAQ : FRED ) has closed the previously announced sale of certain assets of EntrustRx , its specialty pharmacy unit , to a subsidiary of CVS Health Corporation . The aggregate consideration paid was $ 40.0 million , plus an amount equal to the value of inventory of EntrustRx . Commenting on the sale , Fred 's Interim CEO Joe Anto said : " We are pleased to conclude the sale of EntrustRx , an important step in our plans to monetize non - core assets as part of our broader turnaround efforts . The cash proceeds will allow us to pay down a significant portion of our debt and also be used for general corporate purposes " . Fred 's was advised on this transaction by Covington Associates and by Bass Berry & Sims . About Fred 's Inc . Tracing its history back to an original store in Coldwater , Mississippi , opened in 1947 , today Fred ' s , Inc . operates approximately 600 general merchandise and pharmacy stores , including 12 franchised locations . With unique store formats and strategies that combine the best elements of a value - focused retailer with a healthcare - focused drug store , Fred 's stores offer frequently purchased items that address the everyday needs of its customers . This includes nationally recognized brands , proprietary Fred 's label products , and a full range of value - priced selections . For more information about the Company , visit Fred 's website at www.fredsinc.com . Forward Looking Statements Comments in this news release that are not historical facts are forward - looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward - looking statements . A reader can identify forward - looking statements because they are not limited to historical facts or they use such words as " outlook " , " guidance " , " may " , " should " , " could , " " believe " , " anticipate " , " plan " , " expect " , " estimate " , " forecast , " " goal " , " intend " , " committed " , " continue " , or " will likely result " and similar expressions that concern the Company 's strategy , plans , intentions or beliefs about future occurrences or results . These risks and uncertainties include , but are not limited to ( i ) the competitive nature of the industries in which we operate ; ( ii ) the implementation of our strategic plan , and its impact on our sales , costs and operations ; ( iii ) utilizing our existing and new stores and increasing our pharmacy department presence in new and existing stores ; ( iv ) our reliance on a single supplier of pharmaceutical products ; ( v ) our pharmaceutical drug pricing ; ( vi ) reimbursement rates and the terms of our agreements with pharmacy benefit management companies ; ( vii ) our private brands ; ( viii ) the seasonality of our business and the impact of adverse weather conditions ; ( ix ) operational difficulties ; ( x ) merchandise supply and pricing ; ( xi ) consumer demand and product mix ; ( xii ) delayed openings and operating new stores and distribution facilities ; ( xiii ) our employees ; ( xiv ) risks relating to payment processing ; ( xv ) our computer system , and the processes supported by our information technology infrastructure ; ( xvi ) our ability to protect the personal information of our customers and employees ; ( xvii ) cyber - attacks ; ( xviii ) changes in governmental regulations ; ( xix ) the outcome of legal proceedings , including claims of product liability ; ( xx ) insurance costs ; ( xxi ) tax assessments and unclaimed property audits ; ( xxii ) current economic conditions ; ( xxiii ) changes in third - party reimbursements ; ( xxiv ) the terms of our existing and future indebtedness ; ( xxv ) our acquisitions and the ability to effectively integrate businesses that we acquire ; ( xxvi ) our ability to pay dividends ; and the factors listed under " Risk Factors " in the Company 's most recent Annual Report on Form 10 - K and any subsequent quarterly filings on Form 10 - Q filed with the Securities and Exchange Commission . Forward - looking statements speak only as of the date made . The Company undertakes no obligation to release revisions to these forward - looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unforeseen events , except as required to be reported under the rules and regulations of the Securities and Exchange Commission . Contacts Liolios Sean McGowan or Cody Slach , 949 - 574 - 3860 FRED@liolios.com